Cargando…

Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms

Studies reporting clinical symptoms related to electronic nicotine delivery systems (ENDS) usage, especially types of devices and e-liquids, are sparse. The sample included 1,432 current ENDS users, ages 18–64, from a nationwide online survey conducted in 2016. ENDS use included device types, nicoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, Joy L., Payne, Thomas J., Groom, Allison, Tran, Hy, Walker, Kandi L., Kesh, Anshula, Robertson, Rose Marie, Vu, Thanh-Huyen T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683991/
https://www.ncbi.nlm.nih.gov/pubmed/34976675
http://dx.doi.org/10.1016/j.pmedr.2021.101619
_version_ 1784617527173709824
author Hart, Joy L.
Payne, Thomas J.
Groom, Allison
Tran, Hy
Walker, Kandi L.
Kesh, Anshula
Robertson, Rose Marie
Vu, Thanh-Huyen T.
author_facet Hart, Joy L.
Payne, Thomas J.
Groom, Allison
Tran, Hy
Walker, Kandi L.
Kesh, Anshula
Robertson, Rose Marie
Vu, Thanh-Huyen T.
author_sort Hart, Joy L.
collection PubMed
description Studies reporting clinical symptoms related to electronic nicotine delivery systems (ENDS) usage, especially types of devices and e-liquids, are sparse. The sample included 1,432 current ENDS users, ages 18–64, from a nationwide online survey conducted in 2016. ENDS use included device types, nicotine content, flavors, and e-liquid used. Outcomes included any e-cigarette, or vaping, product use-associated lung injury (EVALI)-like symptoms (e.g., cough, shortness of breath, nausea) as well as any clinical symptoms. Of the sample, 50% were female, 23% non-Hispanic (NH) White, 23% NH Black, 54% Hispanic, 18% aged 18–24, 17% LGBTQ, 41% with <$50 K income, 55% 1 + any symptoms, and 33% 1 + any EVALI-like symptoms. Cough and nausea were most prevalent among EVALI-like symptoms (27% and 7.3%, respectively). The proportion having any EVALI-like symptoms was higher in the following groups: younger, Hispanic, current smokers, and current other product users. With multiple adjustments, participants who used refillable devices, varied nicotine content, used flavored products, or made their own e-liquids were more likely to have clinical symptoms than their counterparts. For example, the odds (95% CI) of having 1 + EVALI-like symptoms in participants who used refillable devices with e-liquid pour or e-liquid cartridge replacement were 1.70 (1.13, 2.56) and 1.95 (1.27, 2.99), respectively, compared to the non-refillable group. Use of products (devices and e-liquids) that can be altered and flavored products are associated with higher odds of having clinical symptoms, including EVALI-like symptoms.
format Online
Article
Text
id pubmed-8683991
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-86839912021-12-30 Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms Hart, Joy L. Payne, Thomas J. Groom, Allison Tran, Hy Walker, Kandi L. Kesh, Anshula Robertson, Rose Marie Vu, Thanh-Huyen T. Prev Med Rep Regular Article Studies reporting clinical symptoms related to electronic nicotine delivery systems (ENDS) usage, especially types of devices and e-liquids, are sparse. The sample included 1,432 current ENDS users, ages 18–64, from a nationwide online survey conducted in 2016. ENDS use included device types, nicotine content, flavors, and e-liquid used. Outcomes included any e-cigarette, or vaping, product use-associated lung injury (EVALI)-like symptoms (e.g., cough, shortness of breath, nausea) as well as any clinical symptoms. Of the sample, 50% were female, 23% non-Hispanic (NH) White, 23% NH Black, 54% Hispanic, 18% aged 18–24, 17% LGBTQ, 41% with <$50 K income, 55% 1 + any symptoms, and 33% 1 + any EVALI-like symptoms. Cough and nausea were most prevalent among EVALI-like symptoms (27% and 7.3%, respectively). The proportion having any EVALI-like symptoms was higher in the following groups: younger, Hispanic, current smokers, and current other product users. With multiple adjustments, participants who used refillable devices, varied nicotine content, used flavored products, or made their own e-liquids were more likely to have clinical symptoms than their counterparts. For example, the odds (95% CI) of having 1 + EVALI-like symptoms in participants who used refillable devices with e-liquid pour or e-liquid cartridge replacement were 1.70 (1.13, 2.56) and 1.95 (1.27, 2.99), respectively, compared to the non-refillable group. Use of products (devices and e-liquids) that can be altered and flavored products are associated with higher odds of having clinical symptoms, including EVALI-like symptoms. 2021-10-26 /pmc/articles/PMC8683991/ /pubmed/34976675 http://dx.doi.org/10.1016/j.pmedr.2021.101619 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Hart, Joy L.
Payne, Thomas J.
Groom, Allison
Tran, Hy
Walker, Kandi L.
Kesh, Anshula
Robertson, Rose Marie
Vu, Thanh-Huyen T.
Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms
title Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms
title_full Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms
title_fullStr Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms
title_full_unstemmed Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms
title_short Association between electronic nicotine delivery systems (ENDS) device and E-liquid alterations and flavor use with clinical and EVALI-like symptoms
title_sort association between electronic nicotine delivery systems (ends) device and e-liquid alterations and flavor use with clinical and evali-like symptoms
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683991/
https://www.ncbi.nlm.nih.gov/pubmed/34976675
http://dx.doi.org/10.1016/j.pmedr.2021.101619
work_keys_str_mv AT hartjoyl associationbetweenelectronicnicotinedeliverysystemsendsdeviceandeliquidalterationsandflavorusewithclinicalandevalilikesymptoms
AT paynethomasj associationbetweenelectronicnicotinedeliverysystemsendsdeviceandeliquidalterationsandflavorusewithclinicalandevalilikesymptoms
AT groomallison associationbetweenelectronicnicotinedeliverysystemsendsdeviceandeliquidalterationsandflavorusewithclinicalandevalilikesymptoms
AT tranhy associationbetweenelectronicnicotinedeliverysystemsendsdeviceandeliquidalterationsandflavorusewithclinicalandevalilikesymptoms
AT walkerkandil associationbetweenelectronicnicotinedeliverysystemsendsdeviceandeliquidalterationsandflavorusewithclinicalandevalilikesymptoms
AT keshanshula associationbetweenelectronicnicotinedeliverysystemsendsdeviceandeliquidalterationsandflavorusewithclinicalandevalilikesymptoms
AT robertsonrosemarie associationbetweenelectronicnicotinedeliverysystemsendsdeviceandeliquidalterationsandflavorusewithclinicalandevalilikesymptoms
AT vuthanhhuyent associationbetweenelectronicnicotinedeliverysystemsendsdeviceandeliquidalterationsandflavorusewithclinicalandevalilikesymptoms